Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth A Raetz

Showing results (31-40 of 155) with videos related to

Pageof 16
Sort By:
The Pediatric Infectious Disease Journal|March 26, 2015
Cryptococcal osteomyelitis in an adolescent survivor of T-cell acute lymphoblastic leukemiaDjin-Ye Oh, P Pallavi Madhusoodhan, Deborah J Springer, et al.
Pediatric Blood & Cancer|July 1, 2014
Ikaros deletions in BCR-ABL-negative childhood acute lymphoblastic leukemia are associated with a distinct gene expression signature but do not result in intrinsic chemoresistanceNicholas A Vitanza, Wafik Zaky, Roy Blum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2002
Identification of gene expression profiles that segregate patients with childhood leukemiaPhilip J Moos, Elizabeth A Raetz, Marlee A Carlson, et al.
Leukemia|December 7, 2023
Development of osteonecrosis and improved survival in B-ALL: results of Children's Oncology Group Trial AALL0232Leonard A Mattano, Meenakshi Devidas, Mignon L Loh, et al.
Cancer|August 12, 2003
Identification of genes that are regulated transcriptionally by Myc in childhood tumorsElizabeth A Raetz, Marianne K H Kim, Philip Moos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2008
Reinduction platform for children with first marrow relapse of acute lymphoblastic Leukemia: A Children's Oncology Group Study[corrected]Elizabeth A Raetz, Michael J Borowitz, Meenakshi Devidas, et al.
Leukemia & Lymphoma|January 11, 2019
Plasma asparaginase activity and asparagine depletion in acute lymphoblastic leukemia patients treated with pegaspargase on Children's Oncology Group AALL07P4<sup>.</sup>Reuven J Schore, Meenakshi Devidas, Archie Bleyer, et al.
JCO Clinical Cancer Informatics|May 2, 2025
Performance of Two-Phase Designs for the Time-to-Event Outcome and a Case Study Assessing the Relapse Risk Associated With B-ALL SubtypesWenan Chen, Ti-Cheng Chang, Karen R Rabin, et al.
British Journal of Haematology|April 9, 2019
Bortezomib reinduction chemotherapy in high-risk ALL in first relapse: a report from the Children's Oncology GroupTerzah M Horton, James A Whitlock, Xiaomin Lu, et al.
Haematologica|June 26, 2025
Severe toxicity and poor efficacy of reinduction chemotherapy are associated with overall poor outcomes in relapsed B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group AALL1331 trialLaura E Hogan, Teena Bhatla, Xinxin Xu, et al.
Pageof 16

Showing results (31-40 of 155) with videos related to

Sort By:
Pageof 16
The Pediatric Infectious Disease Journal|March 26, 2015
Cryptococcal osteomyelitis in an adolescent survivor of T-cell acute lymphoblastic leukemiaDjin-Ye Oh, P Pallavi Madhusoodhan, Deborah J Springer, et al.
Pediatric Blood & Cancer|July 1, 2014
Ikaros deletions in BCR-ABL-negative childhood acute lymphoblastic leukemia are associated with a distinct gene expression signature but do not result in intrinsic chemoresistanceNicholas A Vitanza, Wafik Zaky, Roy Blum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2002
Identification of gene expression profiles that segregate patients with childhood leukemiaPhilip J Moos, Elizabeth A Raetz, Marlee A Carlson, et al.
Leukemia|December 7, 2023
Development of osteonecrosis and improved survival in B-ALL: results of Children's Oncology Group Trial AALL0232Leonard A Mattano, Meenakshi Devidas, Mignon L Loh, et al.
Cancer|August 12, 2003
Identification of genes that are regulated transcriptionally by Myc in childhood tumorsElizabeth A Raetz, Marianne K H Kim, Philip Moos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2008
Reinduction platform for children with first marrow relapse of acute lymphoblastic Leukemia: A Children's Oncology Group Study[corrected]Elizabeth A Raetz, Michael J Borowitz, Meenakshi Devidas, et al.
Leukemia & Lymphoma|January 11, 2019
Plasma asparaginase activity and asparagine depletion in acute lymphoblastic leukemia patients treated with pegaspargase on Children's Oncology Group AALL07P4<sup>.</sup>Reuven J Schore, Meenakshi Devidas, Archie Bleyer, et al.
JCO Clinical Cancer Informatics|May 2, 2025
Performance of Two-Phase Designs for the Time-to-Event Outcome and a Case Study Assessing the Relapse Risk Associated With B-ALL SubtypesWenan Chen, Ti-Cheng Chang, Karen R Rabin, et al.
British Journal of Haematology|April 9, 2019
Bortezomib reinduction chemotherapy in high-risk ALL in first relapse: a report from the Children's Oncology GroupTerzah M Horton, James A Whitlock, Xiaomin Lu, et al.
Haematologica|June 26, 2025
Severe toxicity and poor efficacy of reinduction chemotherapy are associated with overall poor outcomes in relapsed B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group AALL1331 trialLaura E Hogan, Teena Bhatla, Xinxin Xu, et al.
Pageof 16